Sections
Shows
Events
Sun Pharma arm seeks USFDA nod for voluntary withdrawal of 28 ANDAs of Ranbaxy
Sun Pharma tanks 10% on dismal Q4; Ranbaxy merger seen hurting in short term
Despite weak stock market here's why Pharma stocks surged today
